Advanced Malignancies That Harbor IDHR132 Mutations
1 clinical trials · Condition
◉ Watch Advanced Malignancies That Harbor IDHR132 Mutations
| Record | Firm | Date |
|---|---|---|
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations (NCT02381886) | Novartis Pharmaceuticals | 2015-03-06 |
Track Advanced Malignancies That Harbor IDHR132 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.